Here's the real pipeline... MODI OBOCHI, PHD MB
Post# of 30028
(Total Views: 1048)
Posted On: 03/07/2019 5:05:08 PM
Here's the real pipeline...
MODI OBOCHI, PHD MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER
Global leadership positions at QLT, Hospira, Pfizer and Baxter spanning general management, commercial, business development and R&D. Expanded Baxter’s $1 billion generic injectable business as the Global VP for Pharmaceuticals Injectables; developed differentiated sterile injectable products for Pfizer; as Head of Global Strategic Marketing at Hospira, accelerated profitable portfolio growth of Hospira’s $3.5 billion sterile injectable pharmaceuticals (including 60 product launches), resulting in the acquisition of Hospira by Pfizer for all cash deal of $15 billion.
MIKE REA
CHIEF COMMERCIAL OFFICER
Currently CEO of IDEA Pharma (ring any bells!!!)
PAULA TRZEPACZ, MD
CHIEF MEDICAL OFFICER
Interesting backgrounds and team they have....the relationships are also something to raise an eyebrow at.
http://coeptispharma.com/executive-team/
Aloha
MODI OBOCHI, PHD MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER
Global leadership positions at QLT, Hospira, Pfizer and Baxter spanning general management, commercial, business development and R&D. Expanded Baxter’s $1 billion generic injectable business as the Global VP for Pharmaceuticals Injectables; developed differentiated sterile injectable products for Pfizer; as Head of Global Strategic Marketing at Hospira, accelerated profitable portfolio growth of Hospira’s $3.5 billion sterile injectable pharmaceuticals (including 60 product launches), resulting in the acquisition of Hospira by Pfizer for all cash deal of $15 billion.
MIKE REA
CHIEF COMMERCIAL OFFICER
Currently CEO of IDEA Pharma (ring any bells!!!)
PAULA TRZEPACZ, MD
CHIEF MEDICAL OFFICER
Interesting backgrounds and team they have....the relationships are also something to raise an eyebrow at.
http://coeptispharma.com/executive-team/
Aloha
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼